TALLAHASSEE, Fla., May 30, 2024 /PRNewswire/ — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced that it has reached an agreement resolving the active litigation. In accordance with the settlement, Trulieve will acquire Harvest of Ohio, LLC, which will hold licenses for medical cannabis dispensaries in Columbus and Beavercreek.  The Harvest of OH medical cannabis dispensary in Athens will be transferred to Ariane Kirkpatrick and will be rebranded under the name Mavuno.  Sep ..read more

TORONTO, May 30, 2024 — Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) is pleased to report it has filed its Condensed Interim Consolidated Financial Statements (“the Financial Statements”), Management’s Discussion and Analysis (“MD&A”), and associated certifications for its first quarter ended March 31, 2024. As a reminder to all of its shareholders, the Company will hold its Annual General Meeting (“AGM”) on Friday, June 14th, 2024. President’s Commentary Colby De Zen, President, stated, “After significant efforts, the Aleafia transaction was successfully closed in ..read more

TALLAHASSEE, Fla., June 3, 2024  — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Brooksville, Florida, marking the Company’s 200th dispensary in the United States. A grand opening celebration will be held Friday, June 14, beginning at 9 a.m., featuring a ribbon-cutting ceremony, food trucks, music, swag giveaways, specials, discounts, and opportunities to learn more about the Smart an ..read more

VANCOUVER, British Columbia, June 03, 2024 – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a leading Health Canada-licensed psychedelics pharmaceutical manufacturer specializing in controlled substances such as botanical psilocybin and MDMA, is pleased to announce that it has been awarded a Drug Establishment Licence (DEL) from Health Canada for the manufacturing and sale of its MDMA and psilocybin capsules. This milestone designation affirms a compliant rating for Good Manufacturing Practices (GMP), enabling the Company to supply MDMA and psilocybin ca ..read more

What aspect of the cannabis sector do you operate in? I’m the Founder and CEO of The Hippie Chick (THC), and yes, the pun is intentional. THC is a Cannabis Concierge & Consulting agency. While we serve anyone with a valid Medical Marijuana card issued by the State of Florida, our focus is on assisting the over-forty demographic. On the concierge side, we provide personalized assistance to patients, offering education, scheduling support for obtaining or renewing Medical Marijuana cards, aiding in product selection, and addressing queries about dosing and packaging. On the consulting front ..read more

MAY 29, 2024 – CLICK HERE             The post CANNABIS NEWS FLORIDA NEWSLETTER MAY 29 2024 appeared first on Cannabis News ..read more

The post INTERVIEW WITH DR TEREL NEWTON FLORIDA MEDICAL DIRECTOR FROM TRULIEVE AT 2024 FMCCE BY CHARLES FELIX FROM CANNABIS NEWS FLORIDA AND FLORIDA MEDICAL CANNABIS PHYSICIANS GROUP appeared first on Cannabis News ..read more

TORONTO, May 28, 2024 — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it has terminated its agreement (the “Sale Agreement”) with Future Farmco Canada Inc. (the “Buyer”), for the sale and leaseback of its property located at 4491 Concession 12 Sunnidale Road, Stayner, Ontario, Canada, L0M 1S0 (the “Peace Naturals Campus”). The Buyer did not satisfy or waive its due diligence and financing condition by the May 27, 2024 deadline, as set forth in the Sale Agreement. All amounts paid by the Buyer as part of a security deposit that were previously hel ..read more

Company preparing to export 160 doses of MDMA and psilocybin under Australia’s Authorized Prescriber Scheme VANCOUVER, British Columbia, May 29, 2024  — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer, specializing in controlled substances such as psilocybin and MDMA, is pleased to announce that it has received an import permit from Mind Medicine Australia (MMA) to export its GMP MDMA and psilocybin capsules to supply approved psychiatrists under Australia’s Authorised Prescriber Scheme. Mind Med ..read more

ART12.11 demonstrates comparable pharmacokinetics compared to Epidiolex® SOLANA BEACH, Calif., May 29, 2024  — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological conditions, today announced Dr. Andrew Yates presented new pre-clinical data on ART12.11 at the CT-CANN24 conference which is being held May 29-30, 2024 at the Hilton London Canary Wharf in London, UK. The presentation, titled “An Aqueous Suspension of a No ..read more